Login to Your Account


Parkinson’s kinase harms via presence, not activity

By Anette Breindl
Science Editor

Tuesday, January 7, 2014
A kinase that is often mutated in Parkinson’s disease, the leucine-rich repeat kinase (LRRK2), leads to trouble not because of its kinase activity, but because it interacts with another culprit in Parkinson’s: the protein alpha-synuclein. Researchers from the Gladstone Institutes published those findings in the Jan. 8, 2014, issue of the Journal of Neuroscience. The clinical symptoms of Parkinson’s disease, a neurodegenerative disorder that leads to motor as well as cognitive problems, are due to the death of neurons in the substantia nigra.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription